Keckley Report April 22, 2019
Paul Keckley

Private equity investment in U.S. healthcare plays a formidable role today and, in all likelihood, even more tomorrow. In most cases, these investors are successful in exploiting weaknesses and opportunities relentlessly while profiting their limited partners. In so doing, they are fundamentally reshaping U.S. healthcare.

BACKGROUND

Private equity (PE) raises its capital from Limited Partners– pension funds, institutional investors, high net worth individuals and others– who entrust funds to their management. Investments range from $25 million up to hundreds of millions for companies poised for near-term growth or to facilitate their buy-outs of other companies.

PE does not invest in start-ups or early stage companies: that’s for venture capital investors recognizing that 70% of these never get out of the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Investments, Trends
Private equity bankruptcies in healthcare explode 112% in 5 years
Arch-backed obesity biotech launches with $290M
Ilant Health Secures $5.5M for Value-Based Obesity Management & Cardiometabolic Health
Cullinan Nets $280M Investment and Targets CD19 in Lupus
Isospec Analytics Secures $1.9M to Transform Molecular Identification

Share This Article